Stockreport

Outlook Therapeutics stock jumps on positive EU CHMP opinion for its wet AMD treatment [Seeking Alpha]

Outlook Therapeutics, Inc.  (OTLK) 
Last outlook therapeutics, inc. earnings: 2/14 08:00 am Check Earnings Report
PDF European Medicines Agency issued a positive opinion concerning the authorization of ONS-5010/LYTENAVA for the treatment of wet age-related macular degeneration in the EU [Read more]